Your browser doesn't support javascript.
loading
IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin-paclitaxel, with or without bevacizumab in patients with advanced cancer.
Yap, Timothy A; Bessudo, Alberto; Hamilton, Erika; Sachdev, Jasgit; Patel, Manish R; Rodon, Jordi; Evilevitch, Lena; Duncan, Meghan; Guo, Wei; Kumar, Sujatha; Lu, Sharon; Dezube, Bruce J; Gabrail, Nashat.
Afiliação
  • Yap TA; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA TYap@mdanderson.org.
  • Bessudo A; California Cancer Associates for Research and Excellence, San Diego, California, USA.
  • Hamilton E; Sara Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA.
  • Sachdev J; HonorHealth Research Institute/TGen, Scottsdale, Arizona, USA.
  • Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida, USA.
  • Rodon J; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Evilevitch L; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Duncan M; Xilio Therapeutics, Waltham, Massachusetts, USA.
  • Guo W; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Kumar S; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Lu S; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Dezube BJ; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Gabrail N; Department of Oncology, Gabrail Cancer Center, Canton, Ohio, USA.
J Immunother Cancer ; 10(3)2022 03.
Article em En | MEDLINE | ID: mdl-35332062
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos